TransMedics Group, Inc.

TMDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$24$35$26$7
Dep. & Amort.$7$7$6$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$9$9$11
Change in WC$28$40-$44-$6
Other Non-Cash$10$0$1$2
Operating Cash Flow$70$92-$3$20
Investing Activities
PP&E Inv.-$8-$9-$27-$14
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$8-$9-$27-$14
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$7$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$3$1
Financing Cash Flow$4$7$3$1
Forex Effect$0$1$0-$1
Net Chg. in Cash$66$90-$27$7
Supplemental Information
Beg. Cash$401$311$337$331
End Cash$466$401$311$337
Free Cash Flow$62$83-$30$6
TransMedics Group, Inc. (TMDX) Financial Statements & Key Stats | AlphaPilot